Clinical Trial

A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity

Name: A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity — clinical trial record (NCT07717814)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The primary objective of the trial is to evaluate the pharmacokinetics (PK) of AMG 133 administered as a single subcutaneous (SC) dose using a liquid drug product in vial compared to a frozen liquid drug product in vial in participants living with overweight or obesity.

Trial Details

NCT Number	NCT07717814
Lead Sponsor	Amgen
Conditions	Overweight and Obesity
Enrollment	154 participants
Start Date	2024-11-26
Primary Completion	2025-05-22 (estimated)
Study Completion	2025-06-02 (estimated)
Updated on ClinicalTrials.gov	2026-07-21